Cargando…
Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic Target
Cytochrome P450-mediated metabolism of arachidonic acid (AA) is an important pathway for the formation of eicosanoids. The ω-hydroxylation of AA generates significant levels of 20-hydroxyeicosatetraenoic acid (20-HETE) in various tissues. In the current review, we discussed the role of 20-HETE in th...
Autores principales: | Elshenawy, Osama H., Shoieb, Sherif M., Mohamed, Anwar, El-Kadi, Ayman O.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374375/ https://www.ncbi.nlm.nih.gov/pubmed/28230738 http://dx.doi.org/10.3390/pharmaceutics9010009 |
Ejemplares similares
-
Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms
por: El-Ghiaty, Mahmoud A., et al.
Publicado: (2020) -
Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites
por: Shoieb, Sherif M., et al.
Publicado: (2020) -
Targeting arachidonic acid–related metabolites in COVID-19 patients: potential use of drug-loaded nanoparticles
por: Shoieb, Sherif M., et al.
Publicado: (2020) -
20-Hydroxyeicosatetraenoic Acid (20-HETE) Modulates Canonical Transient Receptor Potential-6 (TRPC6) Channels in Podocytes
por: Roshanravan, Hila, et al.
Publicado: (2016) -
20-Hydroxyeicosatetraenoic Acid (20-HETE) Is a Novel Activator of Transient Receptor Potential Vanilloid 1 (TRPV1) Channel
por: Wen, Hairuo, et al.
Publicado: (2012)